found that in rats with Jensen sarcoma the serum aldolase was increased; the increase only occurred if the tumour were large, then it was proportional to size. Sibley and Lehninger (1949) showed that the serum aldolase fell after removal of the neoplasm.
Glutamic oxaloacetic tran8aminase
Unless there are secondary deposits in the liver, the serum oxaloacetic transaminase is rarely found to be elevated in patients with carcinomatosis. In work on animals with the Morris hepatoma 5231, Dyer et al. (1961) showed that the glutamic oxaloacetic transaminase tended to be raised. This elevation fell when the tumour was removed. In a more rapidly growing hepatoma, the tumour content of glutamic oxaloacetic transaminase was lower than in the slowly growing Morris hepatoma.
MATERIALS
Samples were obtained from women attending the Well Women's Clinic at St. Bartholomew's Hospital and the Gynaecological Departments of that hospital, the Luton and Dunstable Hospital and Bedford General Hospital. In this paper the women were only classified as normal if there were no detectable cytological or gynaecological lesion.
In the discussion of the enzyme results the following terms are used: 1. Detectable activity. This is used to mean an activity being present, but not to such a level as to suggest malignancy. 2. Elevated activity; this means an activity above the diagnostic level.
METHOD
Samples were obtained in a manner similar to that of Bonham and Gibbs (1962) ; 6-phosphogluconate dehydrogenase was assayed by the methods of Glock and McLean (1953) .
Lactic dehydrogenase
The assay of the lactic dehydrogenase content was a modification of the method of Wroblewski and LaDue (1955) . The reagents were all obtained in a kit from the Boehringer Corporation. The assay was scaled down to be suitable for vaginal fluid.
Calculation:
The results were expressed for convenience in Wroblewski units. 
Glutamic oxaloacetic transarminase
The method used was a modification of the ultraviolet assay described by Karmen, Wroblewski and LaDue (1955 Aldolase A modification of the ultraviolet method of Bruns (1954) was used. In this assay the enzyme activity is determined by linking the reaction to the ultraviolet by the use of triose phosphate isomerase and glycerophosphate dehydrogenase. Bruns unit is defined as that amount of enzyme activity which removed the 0-0446 ,umoles of fructosel-6 diphosphate per hour at 250 C. In this assay, 0-892 ,tmoles of nicotinadenine dinucleotide are reduced during the conversion of 0.0446 ,umoles of fructose 1-6 diphosphate to triose phosphate.
The overall reaction is fructosel-6 diphosphate + 2 nicotinamide adenine dinucleotide (reduced) -*2 glycerol-l-phosphate + 2 nicotinamide adenine dinucleotide.
In a 3 ml assay the optical extinction of 0*0892 ,tmoles nicotinamide adenine dinucleotide phosphate reduced form is 0.18732 optical density units. Thus a change of optical density of 0-18732 optical density units in 1 hour equals 1 Bruns unit. If x the change in 20 minutes, and y _ the mg. of vaginal debris in the assay mixture, the Bruns unit per gram will be given by the following formula:
Bruns unit per gram =0187 x 3 x 1 Glucose-6-phosphate dehydrogenase Glock and McLean (1953) described two methods for the assay of glucose-6-phosphate dehydrogenase. One of the methods has the advantage that it allows the comparison of the two enzymes at pH 7-6. The assay was used. Reagents and materials are modified to suit this assay in the vaginal fluid. 0.5 ml. 01 molar magnesium chloride 0 5 ml. 0.25 molar glycylglycine buffer, pH 7-6 0 2 ml. of a solution containing 0-2 molar trisodium 6 phosphogluconate 0-2 molar glucose-6-phosphate sodium salt 041 ml. vaginal fluid supernatent
The reaction is started by the addition of 0-2 ml. nicotinamide adenine dinucleotide phosphate 10 mg./ml. The blank has 0.2 ml. of distilled water instead of the co-enzyme.
The second cell consists of the same reaction mixture, but contains only 6-phosphogluconate. The difference between the activity from cell one and two gives a measure of the activity due to glucose-6-phosphate dehydrogenase. 16% of samples (4 cases) gave elevated levels of 6-phosphogluconate dehydrogenase, in a previous paper describing a larger series, 588% of normal women had elevated levels (Muir and Canti, 1966 In benign gynaecological lesions (Table II) both enzymes give similar incidence of elevated enzyme results. From Fig. 1 it is apparant that lactic dehydrogenase is more often present in normal vaginal fluid than 6-phosphogluconate dehydrogenase. This difference between the two enzymes would explain the higher incidence of detectable lactic dehydrogenase in cases with gynaecological lesions.
In cases of trichomonas vaginalis both enzymes were affected to a similar degree. There was no sample without elevated enzyme levels. From Table II it is apparent that while it is possible to have an elevated lactic dehydrogenase without an elevated 6-phosphogluconate dehydrogenase, the other distribution is more common. Table III gives an analysis according to the different types of carcinoma. In carcinoma in situ, invasive cervical carcinoma, and carcinoma of the body, the two enzymes give similar results. 6-phosphogluconate dehydrogenase activity gives a better correlation with carcinoma of the ovary than lactic dehydrogenase If the two enzymes had been together, 3 (c) Aldolase
There were 21 normal women in this group. Fig. 4 shows the results. Of the 21 women, only one woman had a level of more than 2,500 units, thus 95 % of these women fell under 2,500 units per gram dry weight. It was decided that this level should be regarded as the upper limit of normal. In 3 cases with trichomonas vaginalis infection, the vaginal aldolase activity was increased in only one, while the vaginal 6-phosphogluconate dehydrogenase was increased in all cases. It appears that the vaginal fluid aldolase contents gives a slightly lower incidence of false positive results than 6-phosphogluconate dehydrogenase.
The results in cases of malignancy are given in Table VI . Of 4 samples from cases of carcinoma in situ, both enzymes failed to detect two cases. In established invasive carcinoma of the cervix, uterus, and ovary, the 6-phosphogluconate dehydrogenase activity correlated more closely with malignancy. Table VII . There were 12 samples from malignant or pre-malignancy conditions. Among these 12 cases there were 8 established carcinomas, in 6 of which glucose-6-phosphate dehydrogenase was elevated to an equal or greater extent than 6-phosphogluconate dehydrogenase at pH 7-6 and pH 90.
In 11 samples from patients with benign conditions are shown only 3 cases in which glucose-6-phosphate dehydrogenase was higher than 6-phosphogluconate dehydrogenase.
There is no evidence that the use of glucose-6-phosphate dehydrogenase increases diagnostic efficiency. One sample from an established carcinoma was missed by 6-phosphogluconate dehydrogenase, while 3 established carcinomas were missed by glucose-6-phosphate dehydrogenase using a similar level of activity to distinguish benign and malignant conditions.
(e) Simultaneous multiple enzyme studies
In a certain number of samples more than 2 enzymes were studied. Nor?mal women.-In 6 samples from normal women, glutamic oxaloacetic transaminase and 6-phosphogluconate dehydrogenase, lactic dehydrogenase, and aldolase activities were estimated. In a further 10 cases the oxaloacetic transaminase, the 6-phosphogluconate dehydrogenase and the aldolase were studied. In 3 samples the activities of 6-phosphogluconate, lactic dehydrogenase and aldolase were also studied. In only 1 sample was the 6-phosphogluconate dehydrogenase and the other enzymes elevated . In 2 of these samples, the glutamic oxaloacetic transaminase was elevated by itself. Women with gynaecological lesions.-In 17 samples the 6-phosphogluconate dehydrogenase, the aldolase, glutamic oxaloacetic transaminase and lactic dehydrogenase were all studied. In 11 samples, 6 phosphogluconate, glutamic oxaloacetic transaminase and aldolase were studied. In the remaining six cases 6 phosphogluconate dehydrogenase, lactic dehydrogenase and glutamic oxaloacetic transaminase activities were also studied. In only 1 case were any other enzymes elevated when the 6-phosphogluconate dehydrogenase was not. In 18 of 34 samples the 6-phosphogluconate dehydrogenase was elevated. Similar results were found with the glutamic oxaloacetic transaminase. In 11 of 23 samples the lactic dehydrogenase was elevated while in 12 of 28 cases the aldolase was elevated.
Each enzyme gave a false positive rate of 48% for lactic dehydrogenase, 43 % for aldolase, 53 % for glutamic oxaloacetic transaminase and 6-phosphogluconate dehydrogenase. It was also found that if samples had an elevated 6-phosphogluconate dehydrogenase, in 58% of these samples the lactic dehydrogenase was also elevated, while in 55 % of the same sample the glutamic oxaloacetic transaminase was elevated. In 53 % the aldolase was elevated. If the lactic dehydrogenase activity in the samples was raised, in 54% of these samples the 6-phosphogluconate dehydrogenase was elevated, in 53 % the glutamic oxaloacetic transaminase, and in 54 % the aldolase. If the glutamic oxaloacetic transaminase was elevated the 6-phosphogluconate dehydrogenase was elevated in 55°%,; the lactic dehydrogenase in 54% and the aldolase in 57%. When the aldolase was elevated the 6-phosphogluconate dehydrogenase was also elevated in 53%; the glutamic oxaloacetic transaminase in 57 % and the lactic dehydrogenase in 55 %. Women with gynaecological malignancies.-In 11 samples of invasive carcinoma of the cervix, the 4 enzymes were studied together, and in one case the oxaloacetic transaminase was not assayed. The results are shown in Table IX . In one sample the 6-phosphogluconate dehydrogenase was not elevated, but neither were any of the other enzymes. In Table X the results are summarised.
In Table XI the results of multiple enzymes in carcinoma of the corpus uteri and ovary are given. In 3 samples from carcinoma uteri 4 enzymes were studied and in 2 samples, 3 enzymes. In only one case was the aldolase diagnostic when the 6-phosphogluconate dehydrogenase was not. In one case oxaloacetic transaminase was the only elevated enzyme. If the 6-phosphogluconate dehydrogenase was elevated, the other enzymes were generally elevated.
Had all 4 enzymes been used, the 5 cases would have been detected. When only the 6-phosphogluconate dehydrogenase, lactic dehydrogenase, and aldolase were used, 4 cases were diagnosed. Individually, of these 3 enzymes, each did as well as the other. In 4 samples from carcinoma of the ovary, no advantage was gained by using more than one enzyme. Three out of four cases were associated with elevated 6-phosphogluconate dehydrogenase, while one case was detected by lactic dehydrogenase, and one by aldolase.
DISCUSSION
In this series the enzymes have all been compared with 6-phosphogluconate dehydrogenase. The number of enzymes studied depends on the amount of vaginal fluid studied. In general it may be said that women with a gynaecological lesion tend to have a higher secretion of vaginal fluid, thus in this series there will tend to be a greater number of cases with elevated levels unassociated with carcinoma. It is thought that this increased secretion is caused by an inflammatory exudate.
Results with lactic dehydrogenase
Normal women.-Lactic dehydrogenase gives a slightly higher incidence of abnormal or elevated activities in this group of women than 6-phosphogluconate dehydrogenase, but a very much higher incidence of detectable enzyme than 6-phosphogluconate dehydrogenase. Unlike 6-phosphogluconate dehydrogenase, this enzyme appears to be rarely absent from the vagina. From Fig. 1 it would appear that in normal women if the 6-phosphogluconate dehydrogenase is elevated, then the activity of lactic deydrogenase is related to the amount of 6-phosphogluconate dehydrogenase.
Benign gynaecological lesions.-One can have a moderate amount of lactic dehydrogenase in the absence of 6-phosphogluconate dehydrogenase in women with benign gynaecological lesions. If there is an elevated 6-phosphogluconate dehydrogenase, lactic dehydrogenase tends to be higher than in those with low 6-phosphogluconate dehydrogenase levels. In these samples the two enzymes gave a similar number of elevated enzyme levels in the benign cases.
Gynaecological malignancy.-Lactic dehydrogenase gave similar results to 6-phosphogluconate dehydrogenase. In these cases there was a closer relationship between the amount of 6-phosphogluconate dehydrogenase and the amount of lactic dehydrogenase detected. It thus appears that little is gained by the use of lactic dehydrogenase instead of 6-phosphogluconate dehydrogenase. In Table V Results with glucose-6-phosphate dehydrogenase
In established carcinoma it was more common for the vaginal fluid glucose-6-phosphate dehydrogenase activity to be elevated to a greater extent than the activity of 6-phosphogluconate dehydrogenase. This finding is in agreement with the work on hepatoma tissue. Unfortunately this finding is not invariable and appears to be of no diagnostic value.
In eight established carcinomas there were only 2 cases in which the glucose-6-phosphate dehydrogenase was not elevated to a greater extent than the 6-phosphogluconate dehydrogenase activity. In both these cases 6-phosphogluconate activities were diagnostic. In a third case both enzymes were not diagnostic. Little seems to be gained by the estimation of both dehydrogenases.
In benign conditions the situation was reversed. In only 3 cases was glucose-6-phosphate dehydrogenase elevated to a greater degree than the 6-phosphogluconate dehydrogenase. The most use the simultaneous study of the two dehydrogenases might have would be to eliminate some of the false positive results.
Results in multiple enzyme studies
In normal women it was found that the 6-phosphogluconate dehydrogenase activity correlates with the other enzyme activity. If this enzyme is not raised it is very rare for any of the others to be raised. In cases with gynaecological lesions the enzyme activities parallel each other. The use of the group of enzymes did not enable one to eliminate any false positive results.
It appears that in these carcinomas, the corpus uteri is the only situation in which multiple studies were of diagnostic advantage.
CONCLUSION
It appears that the use of any of these enzymes by themselves did not improve on 6-phosphogluconate dehydrogenase. The use of a multiple screen by the four enzymes (lactic dehydrogenase, glutamic oxaloacetic transaminase, 6-phosphogluconate dehydrogenase, and aldolase) did not significantly improve on the sole use of 6-phosphogluconate dehydrogenase. It is possible that a combination of 6-phosphogluconate dehydrogenase and lactic dehydrogenase might prove a successful combination.
6-phosphogluconate dehydrogenase has the advantage of not being present in samples of vaginal fluid from normal women. Thus a clear cut distinction can be more easily made. It still has the disadvantage of missing certain cases of carcinoma in situ.
SUMMARY
Multiple enzyme studies have been made of the vaginal fluid in benign and malignant disease of the female genital tract. The results were compared with 6-phosphogluconate dehydrogenase. It appears that none of these enzymes improved on 6-phosphogluconate dehydrogenase.
